Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

S Galmiche, LBL Nguyen, E Tartour… - Clinical Microbiology …, 2022 - Elsevier
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

Current developments and challenges of mRNA vaccines

J Chen, J Chen, Q Xu - Annual Review of Biomedical …, 2022 - annualreviews.org
mRNA vaccines have brought about a great revolution in the vaccine fields owing to their
simplicity and adaptability in antigen design, potential to induce both humoral and cell …

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA …

J Stumpf, T Siepmann, T Lindner, C Karger… - The Lancet Regional …, 2021 - thelancet.com
Background Dialysis and kidney transplant patients are vulnerable populations for COVID-
19 related disease and mortality. Methods We conducted a prospective study exploring the …

Humoral response after SARS-CoV-2 mRNA vaccination in a cohort of hemodialysis patients and kidney transplant recipients

C Danthu, S Hantz, A Dahlem, M Duval… - Journal of the …, 2021 - journals.lww.com
Background Kidney transplant recipients and patients receiving hemodialysis are
immunocompromised populations that are prioritized for COVID-19 vaccination but were …

Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review …

K Manothummetha, N Chuleerarux… - JAMA network …, 2022 - jamanetwork.com
Importance Recipients of solid organ transplant (SOT) experience decreased
immunogenicity after COVID-19 vaccination. Objective To summarize current evidence on …

Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients

JJ Broseta, D Rodríguez-Espinosa, N Rodríguez… - American Journal of …, 2021 - Elsevier
Rationale & Objective Patients with kidney failure who are receiving maintenance dialysis
have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS …

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS‐CoV‐2 vaccination in kidney transplant recipients

M Kantauskaite, L Müller, T Kolb… - American Journal of …, 2022 - Wiley Online Library
Kidney transplant recipients (KTRs) are extremely vulnerable to SARS‐CoV‐2 infection and
show an impaired immune response to SARS‐CoV‐2 vaccination. We analyzed factors …

Occurrence of severe COVID-19 in vaccinated transplant patients

S Caillard, N Chavarot, D Bertrand… - Kidney …, 2021 - pmc.ncbi.nlm.nih.gov
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre-including this research content-immediately …

[HTML][HTML] Review of early immune response to SARS-CoV-2 vaccination among patients with CKD

EJ Carr, A Kronbichler, M Graham-Brown… - Kidney international …, 2021 - Elsevier
The effects of the coronavirus disease-2019 (COVID-19) pandemic, particularly among
those with chronic kidney disease (CKD), who commonly have defects in humoral and …

[HTML][HTML] Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept

N Chavarot, A Morel, M Leruez-Ville, E Vilain… - American Journal of …, 2021 - Elsevier
Poor responses to mRNA COVID-19 vaccine have been reported after 2 vaccine injections
in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral …